A Study of Canagliflozin + Metformin Hydrochloride Immediate Release (IR) Fixed-Dose Combination as an Adjunct to Diet and Exercise to Improve Glycemic Control in Indian Adult Participants With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus Intervention:   Drug: Canagliflozin + Metformin hydrochloride (Fixed Dose Combination) Sponsor:   Johnson & Johnson Private Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials